Naveen Pemmaraju and Musa Yilmaz
Jun 17, 2025, 14:20
Naveen Pemmaraju Highlighted Musa Yilmaz’s EHA 2025 Presentation on DEC/VEN/QUIZ in FLT3-ITD AML
Naveen Pemmaraju, Professor at the Department of Leukemia of MD Anderson Cancer Center, shared a post on X:
“EHA 2025 Wonderful job, oral presentation at European Hematology Association by our own Musa Yilmaz, MD Anderson Cancer Center on DEC/VEN/QUIZ combination for patients with FLT3ITD AML.”
More posts on Hemostasis Today.
-
Jun 24, 2026, 19:43New ASH/ISTH 2026 Guidelines for Pediatric Anticoagulant Prophylaxis of VTE Are Now Live – Blood Journals Portfolio
-
Jun 24, 2026, 18:36Maryam Sardar: Timely Anticoagulation in SMV Thrombosis Complicating Acute Pancreatitis
-
Jun 24, 2026, 17:36Paul Whiteley: Neurodevelopmental and Autism Risks in Fetal and Neonatal Alloimmune Thrombocytopenia
-
Jun 24, 2026, 17:22Kavitha Dev: A Low Platelet Count Isn’t Always Critical, But It Should Never Be Ignored
-
Jun 24, 2026, 17:04Recurrent Cervical Internal Carotid Vasospasm Linked to Autosomal Recessive PTGIS Defect – International Journal of Stroke
-
Jun 24, 2026, 16:49Gaurav Kharya: Bridging the Gap in Safe Blood Access for Patients Who Can’t Wait
-
Jun 24, 2026, 16:40William Wallace: Vitamin C and Collagen Work as One Biological System
-
Jun 24, 2026, 16:32Arlindo Nascimento de Lemos Junior: Thrombus Echogenicity as a Predictor of Post-Thrombotic Syndrome Severity After DVT
-
Jun 24, 2026, 16:09Jimi Olaghere: The Future of Sickle Cell Disease Research Starts With Collaboration